Lilly’s Cyramza Wins Slim Nod, But Steba’s Tookad Falls Hard At US FDA Panel

 
• By Sue Sutter
  
FDA Advisory Committee Feature image
AdComm endorsed Cyramza labeling expansion by slimmest of margins but overwhelmingly recommended against Tookad's approval.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers